Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allo-SCT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Very early researchStudy completedNCT02331706
What this trial is testing

IFN-DLI for Relapsed Acute Leukemia After Allo-SCT

Who this might be right for
Leukemia
Abramson Cancer Center at Penn Medicine 16
Large-scale testing (Phase 3)Study completedNCT04173533
What this trial is testing

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasia
University of Birmingham 326
Not applicableStudy completedNCT04386928
What this trial is testing

ALLO-SCT in Elderly Patients With Hematological Disease

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 1,996
Testing effectiveness (Phase 2)Study completedNCT01392079
What this trial is testing

Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine

Who this might be right for
Chronic Lymphocytic Leukemia
University of Ulm 135
Testing effectiveness (Phase 2)Study completedNCT03700450
What this trial is testing

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 37
Early research (Phase 1)Ended earlyNCT01274377
What this trial is testing

Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT

Who this might be right for
Cytomegalovirus Infections
Nelson Chao 5
Large-scale testing (Phase 3)UnknownNCT01955772
What this trial is testing

Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.

Who this might be right for
Myeloablative Allo-SCT
University Hospital, Clermont-Ferrand 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT07232953
What this trial is testing

Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukaemia (AML)Hematopoietic Stem Cell Transplant (HSCT)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 82
Not applicableStudy completedNCT01687231
What this trial is testing

Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets

Who this might be right for
Hematologic Malignancies
Duke University 47
Testing effectiveness (Phase 2)Study completedNCT00580034
What this trial is testing

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 176
Not applicableLooking for participantsNCT07420790
What this trial is testing

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Who this might be right for
Acute Myeloid Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941
Testing effectiveness (Phase 2)Ended earlyNCT05447663
What this trial is testing

Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Stem Cell Transplantation
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT02872662
What this trial is testing

Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT

Who this might be right for
MDSSCTMRD
Nordic MDS Group 308
Testing effectiveness (Phase 2)Ended earlyNCT03689894
What this trial is testing

Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT

Who this might be right for
Chronic Graft-versus-host-disease
Dartmouth-Hitchcock Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT02876679
What this trial is testing

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

Who this might be right for
Graft vs Host Disease
Assistance Publique - Hôpitaux de Paris 94